Works matching AU Fukuda, Minoru


Results: 140
    1

    Sulfated glycans control lymphocyte homing.

    Published in:
    Annals of the New York Academy of Sciences, 2012, v. 1253, n. 1, p. 112, doi. 10.1111/j.1749-6632.2011.06356.x
    By:
    • Kawashima, Hiroto;
    • Fukuda, Minoru
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Polysialic acid facilitates tumor invasion by glioma cells.

    Published in:
    Glycobiology, 2005, v. 15, n. 9, p. 887, doi. 10.1093/glycob/cwi071
    By:
    • Masami Suzuki;
    • Misa Suzuki;
    • Jun Nakayama;
    • Atsushi Suzuki;
    • Kiyohiko Angata;
    • Shihao Chen;
    • Keiichi Sakai;
    • Kazuki Hagihara;
    • Yu Yamaguchi;
    • Minoru Fukuda
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4221, doi. 10.3390/jcm10184221
    By:
    • Dotsu, Yosuke;
    • Yamaguchi, Hiroyuki;
    • Fukuda, Minoru;
    • Suyama, Takayuki;
    • Honda, Noritaka;
    • Umeyama, Yasuhiro;
    • Taniguchi, Hirokazu;
    • Gyotoku, Hiroshi;
    • Takemoto, Shinnosuke;
    • Tagawa, Ryuta;
    • Ogata, Ryosuke;
    • Tomono, Hiromi;
    • Shimada, Midori;
    • Senju, Hiroaki;
    • Nakatomi, Katsumi;
    • Nagashima, Seiji;
    • Soda, Hiroshi;
    • Ikeda, Hiroaki;
    • Ashizawa, Kazuto;
    • Mukae, Hiroshi
    Publication type:
    Article
    20

    Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1762, doi. 10.3390/jcm9061762
    By:
    • Nakao, Akira;
    • Hiranuma, Osamu;
    • Uchino, Junji;
    • Sakaguchi, Chikara;
    • Araya, Tomoyuki;
    • Hiraoka, Noriya;
    • Ishizuka, Tamotsu;
    • Takeda, Takayuki;
    • Kawasaki, Masayuki;
    • Goto, Yasuhiro;
    • Imai, Hisao;
    • Hattori, Noboru;
    • Nakatomi, Keita;
    • Uramoto, Hidetaka;
    • Uryu, Kiyoaki;
    • Fukuda, Minoru;
    • Uchida, Yasuki;
    • Yokoyama, Toshihide;
    • Akai, Masaya;
    • Mio, Tadashi
    Publication type:
    Article
    21
    22

    Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.

    Published in:
    Oncologist, 2022, v. 27, n. 11, p. 903, doi. 10.1093/oncolo/oyac193
    By:
    • Chihara, Yusuke;
    • Takeda, Takayuki;
    • Goto, Yasuhiro;
    • Nakamura, Yoichi;
    • Tsuchiya-Kawano, Yuko;
    • Nakao, Akira;
    • Onoi, Keisuke;
    • Hibino, Makoto;
    • Fukuda, Minoru;
    • Honda, Ryoichi;
    • Yamada, Takahiro;
    • Taniguchi, Ryusuke;
    • Sakamoto, Sinjiro;
    • Date, Koji;
    • Nagashima, Seiji;
    • Tanzawa, Shigeru;
    • Minato, Koichi;
    • Nakatani, Koichi;
    • Izumi, Miiru;
    • Shimose, Takayuki
    Publication type:
    Article
    23

    Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.

    Published in:
    Oncologist, 2019, v. 24, n. 5, p. 593, doi. 10.1634/theoncologist.2019-0003
    By:
    • Nakao, Akira;
    • Hiranuma, Osamu;
    • Uchino, Junji;
    • Sakaguchi, Chikara;
    • Kita, Toshiyuki;
    • Hiraoka, Noriya;
    • Ishizuka, Tamotsu;
    • Kubota, Yutaka;
    • Kawasaki, Masayuki;
    • Goto, Yasuhiro;
    • Imai, Hisao;
    • Hattori, Noboru;
    • Nakatomi, Keita;
    • Uramoto, Hidetaka;
    • Uryu, Kiyoaki;
    • Fukuda, Minoru;
    • Uchida, Yasuki;
    • Yokoyama, Toshihide;
    • Akai, Masaya;
    • Mio, Tadashi
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.

    Published in:
    2020
    By:
    • Nonaka, Motohiro;
    • Suzuki-Anekoji, Misa;
    • Nakayama, Jun;
    • Mabashi-Asazuma, Hideaki;
    • Jarvis, Donald L.;
    • Yeh, Jiunn-Chern;
    • Yamasaki, Kazuhiko;
    • Akama, Tomoya O.;
    • Huang, Chun-Teng;
    • Campos, Alexandre Rosa;
    • Nagaoka, Masato;
    • Sasai, Toshio;
    • Kimura-Takagi, Itsuko;
    • Suwa, Yoichi;
    • Yaegashi, Takashi;
    • Shibata, Toshiaki K.;
    • Sugihara, Kazuhiro;
    • Nishizawa-Harada, Chizuko;
    • Fukuda, Minoru;
    • Fukuda, Michiko N.
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Essential role of gastric gland mucin in preventing gastric cancer in mice.

    Published in:
    Journal of Clinical Investigation, 2012, v. 122, n. 3, p. 923, doi. 10.1172/JCI59087
    By:
    • Karasawa, Fumitoshi;
    • Shiota, Akira;
    • Goso, Yukinobu;
    • Kobayashi, Motohiro;
    • Sato, Yoshiko;
    • Masumoto, Junya;
    • Fujiwara, Maiko;
    • Yokosawa, Shuichi;
    • Muraki, Takashi;
    • Miyagawa, Shinichi;
    • Ueda, Masatsugu;
    • Fukuda, Michiko N.;
    • Fukuda, Minoru;
    • Ishihara, Kazuhiko;
    • Nakayama, Jun
    Publication type:
    Article
    40
    41
    42

    A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 497, doi. 10.1007/s00280-014-2527-4
    By:
    • Ikeda, Takaya;
    • Fukuda, Minoru;
    • Nakamura, Yoichi;
    • Kinoshita, Akitoshi;
    • Senju, Hiroaki;
    • Nakano, Hirofumi;
    • Kitazaki, Takeshi;
    • Ogawara, Daiki;
    • Taniguchi, Hirokazu;
    • Motoshima, Kohei;
    • Yamaguchi, Hiroyuki;
    • Nakatomi, Katsumi;
    • Shimada, Midori;
    • Nagashima, Seiji;
    • Tsukamoto, Kazuhiro;
    • Kohno, Shigeru
    Publication type:
    Article
    43
    44

    Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1299, doi. 10.1007/s00280-013-2307-6
    By:
    • Motoshima, Kohei;
    • Nakamura, Yoichi;
    • Sano, Kazumi;
    • Ikegami, Yoji;
    • Ikeda, Takaya;
    • Mizoguchi, Kosuke;
    • Takemoto, Shinnosuke;
    • Fukuda, Minoru;
    • Nagashima, Seiji;
    • Iida, Tetsuya;
    • Tsukamoto, Kazuhiro;
    • Kohno, Shigeru
    Publication type:
    Article
    45
    46
    47
    48
    49
    50